These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 10208143

  • 1. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
    Strawford A, Barbieri T, Van Loan M, Parks E, Catlin D, Barton N, Neese R, Christiansen M, King J, Hellerstein MK.
    JAMA; 1999 Apr 14; 281(14):1282-90. PubMed ID: 10208143
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting.
    Hengge UR, Stocks K, Wiehler H, Faulkner S, Esser S, Lorenz C, Jentzen W, Hengge D, Goos M, Dudley RE, Ringham G.
    AIDS; 2003 Mar 28; 17(5):699-710. PubMed ID: 12646793
    [Abstract] [Full Text] [Related]

  • 3. Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.
    Hengge UR, Stocks K, Faulkner S, Wiehler H, Lorenz C, Jentzen W, Hengge D, Ringham G.
    HIV Clin Trials; 2003 Mar 28; 4(3):150-63. PubMed ID: 12815555
    [Abstract] [Full Text] [Related]

  • 4. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
    Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A.
    Ann Intern Med; 1998 Jul 01; 129(1):18-26. PubMed ID: 9652995
    [Abstract] [Full Text] [Related]

  • 5. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A.
    J Clin Endocrinol Metab; 1996 Nov 01; 81(11):4051-8. PubMed ID: 8923860
    [Abstract] [Full Text] [Related]

  • 6. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.
    Bhasin S, Storer TW, Javanbakht M, Berman N, Yarasheski KE, Phillips J, Dike M, Sinha-Hikim I, Shen R, Hays RD, Beall G.
    JAMA; 2000 Feb 09; 283(6):763-70. PubMed ID: 10683055
    [Abstract] [Full Text] [Related]

  • 7. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
    Strawford A, Barbieri T, Neese R, Van Loan M, Christiansen M, Hoh R, Sathyan G, Skowronski R, King J, Hellerstein M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb 01; 20(2):137-46. PubMed ID: 10048900
    [Abstract] [Full Text] [Related]

  • 8. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M, ACTG 313 Study Team.
    J Clin Endocrinol Metab; 2007 Feb 01; 92(2):563-70. PubMed ID: 17090640
    [Abstract] [Full Text] [Related]

  • 9. Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study.
    Grunfeld C, Kotler DP, Dobs A, Glesby M, Bhasin S.
    J Acquir Immune Defic Syndr; 2006 Mar 01; 41(3):304-14. PubMed ID: 16540931
    [Abstract] [Full Text] [Related]

  • 10. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.
    Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, Anderson E, Stanley T, Schoenfeld D, Burrows B, Hayden D, Basgoz N, Klibanski A.
    Ann Intern Med; 2000 Sep 05; 133(5):348-55. PubMed ID: 10979879
    [Abstract] [Full Text] [Related]

  • 11. The use of testosterone in the AIDS wasting syndrome.
    Corcoran C, Grinspoon S.
    AIDS Clin Care; 1999 Apr 05; 11(4):25-6, 33-4. PubMed ID: 11366208
    [Abstract] [Full Text] [Related]

  • 12. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S.
    J Clin Endocrinol Metab; 2000 Jan 05; 85(1):35-41. PubMed ID: 10634360
    [Abstract] [Full Text] [Related]

  • 13. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial.
    Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T.
    J Am Soc Nephrol; 2006 Aug 05; 17(8):2307-14. PubMed ID: 16825332
    [Abstract] [Full Text] [Related]

  • 14. Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy.
    Van Loan MD, Strawford A, Jacob M, Hellerstein M.
    AIDS; 1999 Feb 04; 13(2):241-8. PubMed ID: 10202830
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
    Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM.
    JAMA; 2002 Nov 13; 288(18):2282-92. PubMed ID: 12425705
    [Abstract] [Full Text] [Related]

  • 16. Body cell mass repletion and improved quality of life in HIV-infected individuals receiving oxandrolone.
    Earthman CP, Reid PM, Harper IT, Ravussin E, Howell WH.
    JPEN J Parenter Enteral Nutr; 2002 Nov 13; 26(6):357-65. PubMed ID: 12405647
    [Abstract] [Full Text] [Related]

  • 17. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
    Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, Padero M, Mac P, Yarasheski KE, Geurts P, Willemsen A, Harms MK, Bhasin S.
    J Clin Endocrinol Metab; 2005 Aug 13; 90(8):4474-82. PubMed ID: 15914526
    [Abstract] [Full Text] [Related]

  • 18. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S, Corcoran C, Stanley T, Katznelson L, Klibanski A.
    J Clin Endocrinol Metab; 1998 Dec 13; 83(12):4251-6. PubMed ID: 9851759
    [Abstract] [Full Text] [Related]

  • 19. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
    Johansen KL, Mulligan K, Schambelan M.
    JAMA; 1999 Apr 14; 281(14):1275-81. PubMed ID: 10208142
    [Abstract] [Full Text] [Related]

  • 20. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
    Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK.
    J Clin Endocrinol Metab; 2001 May 14; 86(5):2020-6. PubMed ID: 11344201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.